Detail akcie SI-BONE Rg online

Business Summary: SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, SI-Bone Inc revenues increased 22% to $144.6M. Net loss decreased 35% to $17.3M. Revenues reflect United States segment increase of 23% to $137.6M, International segment increase of 4% to $6.9M. Lower net loss reflects Medical device segment loss decrease of 33% to $19.9M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.64 to -$0.40.